Thursday, November 12, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleIEEE Spectrum

Watershed Moment for AI–Human Collaboration in Math

View original at spectrum.ieee.org
IEEE Spectrum - Technical Title: Watershed Moment for AI–Human Collaboration in Math Date: 2026-03-02 18:00 Source: https://spectrum.ieee.org/ai-proof-verification <img src="https://spectrum.ieee.org/media-library/four-by-four-grid-of-circles-with-varying-color-gradient-patterns.jpg?id=65103143&width=2000&height=1500&c…
Opening lines of the source · IEEE Spectrum · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • These new results seem very, very impressive, and definitely signal some rapid progress in this direction

    80% confidence
  • This is technology that we're very excited about, because it has the capability to do great things and to assist mathematicians in remarkable ways

    80% confidence
  • They told us that they had finished 30 sorrys, which meant that they proved 30 intermediate facts that we wanted proved

    80% confidence
  • Formal verification of a proof is like a rubber stamp. It's a kind of bona fide certification that you know your statements of reasoning are correct

    80% confidence
  • A programmer used to be someone who punched holes into cards, but then the act of programming became separated from whatever material substrate was used for recording programs

    80% confidence
  • The end result of technology like this will be to free mathematicians to do what they do best, which is to dream of new mathematical worlds

    80% confidence
  • In late October we heard from Math, Inc. for the first time

    80% confidence
  • When they reached out to us in late January saying that they finished it, to put it very mildly, we were very surprised

    80% confidence
  • This new version reproduced our three-week PNT result in two to three days

    80% confidence
  • It was a pretty fruitful collaboration

    80% confidence
  • We made a research breakthrough sometime mid-January that produced a much stronger version of Gauss

    80% confidence
  • Gauss is a particular kind of language model called a reasoning agent that's meant to interleave both traditional natural-language reasoning and fully formalized reasoning

    80% confidence
  • One of the proofs from Math, Inc. helped us identify a typo in our project, which we then fixed

    80% confidence
  • Gauss is able to conduct literature searches, call up tools, and use a computer to write down Lean code, take notes, spin up verification tooling, run the Lean compiler, et cetera

    80% confidence
  • We had been building the project's repository for about 15 months when we enabled public access in June 2025

    80% confidence
  • The 24-dimensional case was actually significantly more involved than the 8-dimensional case, because there was a lot of missing background material that had to be brought on line surrounding many of the properties of the Leech lattice, in particular its uniqueness

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com